At a glance
- Short name
- Genetic Testing Compliance (CLIA/FDA)
- Issuing / stewarding body
- NIH NHGRI
- Jurisdiction
- US
- Also known as / related labels
- CLIA (Clinical Laboratory Improvement Amendments) · FDA Laboratory Developed Tests (LDT) Oversight · ACMG Standards and Guidelines · CAP Molecular Pathology Checklist · State Genetic Testing Laws
What this entry covers
Assessment for clinical genetic testing laboratories covering CLIA high-complexity testing, FDA LDT oversight, and genetic counseling requirements
MyRHC indexes this framework so practitioners, auditors, and automated agents can find the authoritative primary sources in one place. This page is a navigation aid — it is not legal advice and is not a substitute for the official text.
Official documentation
- Primary official source: https://www.genome.gov/about-genomics/policy-issues/Genetic-Discrimination
How to use this index entry
- Open the official link above (or the agency home if the deep link drifts).
- Confirm edition / revision date against your program scope.
- Map applicability by sector and jurisdiction listed in the metadata.
- Follow related frameworks only after checking their own official sources.
Disclaimers
- MyRHC does not host proprietary standards text (ISO, some industry bodies).
- Where standards are paywalled, we link to the publisher’s catalog page.
- Always verify current requirements with counsel and the issuing authority.
Index only — not legal advice.
MyRHC does not certify compliance. Confirm current requirements with the issuing authority and qualified counsel. Proprietary standards text remains with its publisher.